[
  {
    "title": "仁度生物(688193.SH)：副总经理明辉升任总经理",
    "href": "http://stock.jrj.com.cn/2022/12/09154837201516.shtml",
    "datetime": "2022-12-09 15:48:31",
    "code": "688193"
  },
  {
    "title": "仁度生物2022年前三季度净利2375.47万同比减少53.62% 期间费用增长",
    "href": "http://stock.jrj.com.cn/2022/10/28225037096164.shtml",
    "datetime": "2022-10-28 22:50:42",
    "code": "688193"
  },
  {
    "title": "仁度生物(688193.SH)：第三季度净利降89.92%至183.31万元",
    "href": "http://stock.jrj.com.cn/2022/10/28172737094305.shtml",
    "datetime": "2022-10-28 17:27:31",
    "code": "688193"
  },
  {
    "title": "仁度生物(688193)：本次限售股上市日为2022年9月30日",
    "href": "http://stock.jrj.com.cn/2022/09/22091637013060.shtml",
    "datetime": "2022-09-22 09:16:08",
    "code": "688193"
  },
  {
    "title": "仁度生物(688193.SH)：35.96万股限售股将于9月30日解禁上市",
    "href": "http://stock.jrj.com.cn/2022/09/21171837011460.shtml",
    "datetime": "2022-09-21 17:18:00",
    "code": "688193"
  },
  {
    "title": "仁度生物2022年上半年净利2192.16万同比减少33.64% 新冠试剂销售收入及毛利率下降",
    "href": "http://stock.jrj.com.cn/2022/08/17215136909698.shtml",
    "datetime": "2022-08-17 21:51:57",
    "code": "688193"
  },
  {
    "title": "仁度生物：获得全自动核酸检测分析系统等5项欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2022/06/07192736710132.shtml",
    "datetime": "2022-06-07 19:27:12",
    "code": "688193"
  },
  {
    "title": "仁度生物(688193.SH)：5项相关检测产品获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2022/06/07180936709793.shtml",
    "datetime": "2022-06-07 18:09:49",
    "code": "688193"
  },
  {
    "title": "仁度生物：猴痘病毒核酸检测试剂盒等17项产品获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2022/05/26155936681083.shtml",
    "datetime": "2022-05-26 15:59:40",
    "code": "688193"
  },
  {
    "title": "仁度生物(688193.SH)：17项产品获得欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2022/05/26155336681101.shtml",
    "datetime": "2022-05-26 15:53:13",
    "code": "688193"
  },
  {
    "title": "仁度生物(688193.SH)：实控人、董监高等延长股份锁定期",
    "href": "http://stock.jrj.com.cn/2022/05/12154036642852.shtml",
    "datetime": "2022-05-12 15:40:28",
    "code": "688193"
  },
  {
    "title": "仁度生物2022年第一季度净利1680.66万 较上年同期下滑13.54%",
    "href": "http://stock.jrj.com.cn/2022/04/25201336467199.shtml",
    "datetime": "2022-04-25 20:13:00",
    "code": "688193"
  },
  {
    "title": "仁度生物(688193.SH)一季度净利润1680.66万元 同比下降13.54%",
    "href": "http://stock.jrj.com.cn/2022/04/24154436447555.shtml",
    "datetime": "2022-04-24 15:44:22",
    "code": "688193"
  },
  {
    "title": "科创板新股仁度生物开盘破发",
    "href": "http://stock.jrj.com.cn/2022/03/30093936182690.shtml",
    "datetime": "2022-03-30 09:39:00",
    "code": "688193"
  },
  {
    "title": "南京高科(600064.SH)：仁度生物3月30日正式登陆科创板",
    "href": "http://stock.jrj.com.cn/2022/03/29162336144532.shtml",
    "datetime": "2022-03-29 16:23:02",
    "code": "688193"
  },
  {
    "title": "仁度生物(688193.SH)：将于3月30日在科创板上市",
    "href": "http://stock.jrj.com.cn/2022/03/28190335915946.shtml",
    "datetime": "2022-03-28 19:03:17",
    "code": "688193"
  },
  {
    "title": "仁度生物(688193.SH)IPO认购结果：网上网下共弃购15.37万股",
    "href": "http://stock.jrj.com.cn/2022/03/24200434932677.shtml",
    "datetime": "2022-03-24 20:04:27",
    "code": "688193"
  },
  {
    "title": "仁度生物(688193.SH)：中金财富获配50万股、网上摇号中签号共6809个",
    "href": "http://stock.jrj.com.cn/2022/03/22191134861808.shtml",
    "datetime": "2022-03-22 19:11:10",
    "code": "688193"
  },
  {
    "title": "仁度生物(688193.SH)：网上发行最终中签率约为0.031%",
    "href": "http://stock.jrj.com.cn/2022/03/21193634857153.shtml",
    "datetime": "2022-03-21 19:36:47",
    "code": "688193"
  },
  {
    "title": "仁度生物IPO：业绩大增 主业务收入却萎缩 研发投入占比连续下降",
    "href": "http://stock.jrj.com.cn/2022/03/03091034515229.shtml",
    "datetime": "2022-03-03 09:10:00",
    "code": "688193"
  },
  {
    "title": "南京高科(600064.SH)：股权投资业务参投项目仁度生物科创板IPO过会",
    "href": "http://stock.jrj.com.cn/2021/11/15153933854434.shtml",
    "datetime": "2021-11-15 15:39:47",
    "code": "688193"
  },
  {
    "title": "坤恒顺维新三板转板科创板IPO通过审核，仁度生物成功过审",
    "href": "http://stock.jrj.com.cn/2021/11/15102733853221.shtml",
    "datetime": "2021-11-15 10:27:56",
    "code": "688193"
  },
  {
    "title": "两轮问询回复齐迎上会，仁度生物、坤恒顺维11月12日接受科创板IPO审核",
    "href": "http://stock.jrj.com.cn/2021/11/08105533822455.shtml",
    "datetime": "2021-11-08 10:55:30",
    "code": "688193"
  },
  {
    "title": "仁度生物：依托新冠检测业绩高增长或难持续 核心技术市场推广难度较大",
    "href": "http://stock.jrj.com.cn/ipo/2021/11/03082433806733.shtml",
    "datetime": "2021-11-03 08:24:10",
    "code": "688193"
  },
  {
    "title": "华盖低价入股后又高价转让？仁度生物科创板问询这样解答",
    "href": "http://stock.jrj.com.cn/2021/10/28092133767100.shtml",
    "datetime": "2021-10-28 09:21:47",
    "code": "688193"
  },
  {
    "title": "是否存在利益输送？是否存在市场空间有限的风险？仁度生物答科创板首轮25问",
    "href": "http://stock.jrj.com.cn/2021/08/31091333358781.shtml",
    "datetime": "2021-08-31 09:13:25",
    "code": "688193"
  },
  {
    "title": "再下一城！仁度生物冲刺科创板IPO进入“已问询”状态",
    "href": "http://stock.jrj.com.cn/2021/07/08095533062738.shtml",
    "datetime": "2021-07-08 09:55:37",
    "code": "688193"
  },
  {
    "title": "仁度生物冲刺科创板IPO：如何破解疫情带来业绩波动风险？",
    "href": "http://stock.jrj.com.cn/2021/06/18100532952863.shtml",
    "datetime": "2021-06-18 10:05:23",
    "code": "688193"
  },
  {
    "title": "4家企业启动IPO辅导：仁度生物曾获华盖资本近亿元投资",
    "href": "http://stock.jrj.com.cn/2020/11/10183731252523.shtml",
    "datetime": "2020-11-10 18:37:27",
    "code": "688193"
  },
  {
    "title": "仁度生物启动科创板上市辅导 曾获华盖资本近亿元投资",
    "href": "http://stock.jrj.com.cn/2020/11/10103731249360.shtml",
    "datetime": "2020-11-10 10:37:53",
    "code": "688193"
  },
  {
    "title": "仁度生物拟科创板挂牌 新冠核酸检测试剂盒年初快速通过应急审批",
    "href": "http://stock.jrj.com.cn/kcb/2020/11/10082831247637.shtml",
    "datetime": "2020-11-10 08:28:10",
    "code": "688193"
  }
]